Anellotech

Photo

Japanese JV Invests in Anellotech Process

A newly formed Japanese joint-venture company is investing in Anellotech’s Plas-TCat plastics recycling process, with the aim of commercializing the technology by 2027.R Plus Japan was established last month by 12 cross-industry partners within the Japanese plastics supply chain.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.